Online Safety Community

Understanding the FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials

The establishment of the initial safety of a drug is the primary reason for which early clinical trials are conducted. Phase I of drug development consists of:

o  Research and drug discovery

o  Preclinical development, of which initial IND, or first in humans (also called first in man), is part

o  Clinical development, which consists of Phase I, Phase 2 and Phase 3 clinical pharmacology studies

Phase I studies are designed mainly for investigating the following qualities of an investigational drug in humans:

o  The extent to which it is safe and tolerable: (if possible, identify its Maximum Tolerated Dose (MTD)

o  Pharmacokinetics

o  Pharmacodynamics of an investigational drug in humans.

The ultimate goal of these Phase I and later studies is to ensure that the right drug is given to the right patient in the right dose, at the right time. These clinical studies are carried out to determine which dose or dosing regimen of the target drug achieves all its objectives for all the populations groups for which it is being developed.

Rationale for a small sample

Generally, these studies are carried out on a small sample of subjects of normal health. These early clinical trials normally use lower doses of the drug product. On account of this, the organization or laboratory carrying out these early stage clinical studies uses only small amounts of investigational material.

This is because of two reasons: The small sample is chosen in such a fashion that it is a representation of the whole study in relation to various parameters, and two, choosing a small sample substantially reduces the costs associated with a largescale study. It also reduces the regulatory burden during these early stages. Keeping in mind these factors, the FDA has established guidelines by which early stage investigational products can be allowed to be manufactured under less stringent GMPs.

Not meeting regulatory requirements makes the exercise futile

Without an understanding of the FDA’s guidelines for these GMPs, the whole exercise of early or Phase I studies becomes wasteful and meaningless. All along, the FDA’s guidelines have to be consistently and accurately adhered to in order to meet compliance requirements, without which the clinical trial and its results do not get approved.

What are the steps that a clinical or pharmaceutical organization need to take in order to ensure that these GMPs for Phase I clinical trials are being met? All the aspects of this topic will be covered in depth over two days of intense learning that will be imparted at a seminar from GlobalCompliancePanel, a leading provider of professional trainings for the areas of regulatory compliance.

Peggy Berry, the President and CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development, will be the Director of this seminar. All that is needed to gain from the rich wealth of Peggy’s experience is to register for this seminar by logging on to Good Manufacturing Practices . This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant’s RAC recertification upon full completion.

A complete explanation of the FDA’s GMP requirements

This seminar is being organized to help participants gain an understanding of the requirements for advancing drugs from research into early clinical development and the minimum FDA requirements for Phase I GMPs. She will help them learn practical applications for implementing Phase I manufacturing strategies to meet FDA requirements.

Towards this end, Peggy will discuss these topics to lay the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products on Day 1:

o  Moving a Product out of R&D

o  CMC Requirements for an IND Study

o  Good Manufacturing Practices: Basics for Beginners

o  Raw Material Management

Taking off from these topics, Peggy will focus on the topics relating to the requirements for early stage products of different types and for vendor selection and management on Day 2, which include:

o  GMPs for Phase I IND products

o  GMPs for Combination Products and 505(b)(2) Products

o  Process Validation for Early Stage GMP

o  Outsourcing Early Stage Manufacturing.

Views: 111

Comment

You need to be a member of Online Safety Community to add comments!

Join Online Safety Community

Take our poll!

Take our poll!

Latest Activity

Russel Stuart posted an event
Thumbnail

Time Management at Online evnt

October 5, 2017 from 10am to 11am
The TrainHR webinar is approved by HRCI and SHRM Recertification Provider.Overview: Everyone gets the same amount of hours in a day, week, month and year. So, why is it that some people get so much more done than others? Time can be one of the most elusive resources a business owner and/or manager have. You may have a system for running all the other aspects of your business. But, are you managing your time efficiently and effectively?What is Time Management? Time Management refers to managing…See More
16 hours ago
Madison Quinn posted a discussion

QlikView 12.10 Service Release 8 and QlikView Governance Dashboard 2.0.4 now available

Hello all,Qlik announced that QlikView 12.10 Service Release 8 [SR8] is now available on Qlik download site.   SR8 is a relatively small service release and includes 7 bug fixes - you can find details of the fixes in the attached release notes.Also Qlik announced that QlikView Governance Dashboard 2.0.4 is available on Qlik download site. This release contains a few key bug fixes which are detailed in the attached release…See More
yesterday
John Robinson posted blog posts
yesterday
rodriguezcecelia posted an event

ITIL Training Seattle, WA at Regus, Seattle

August 30, 2017 at 9am to August 31, 2017 at 5pm
Welcome to MSys Training, North America’s leading training provider. Read some of our reviews on www.trustpilot.com. MSys’ ITIL Foundation® program includes:Course instruction by Lead ITIL instructorsAXELOS® approved course material2 Simulation testsCase studies, webinars and instructor feedback16 PDU certificate100% pass guarantee Visit www.msystraining.com, call 408-878-3078 or…See More
yesterday

Forum

QlikView 12.10 Service Release 8 and QlikView Governance Dashboard 2.0.4 now available

Hello all,Qlik announced that QlikView 12.10 Service Release 8 [SR8] is now available on Qlik download site.   SR8 is a…Continue

Started by Madison Quinn yesterday.

PMP Certification Boot Camp Los Angeles

Welcome to MSys Training, North America’s leading training provider. Read some of our reviews on www.trustpilot.com. MSys’ PMP® program…Continue

Tags: PMP

Started by rodriguezcecelia yesterday.

Safety - A Prerequisite 11 Replies

Whether working at home or outside, to observe safety should be our pre-requisite. The employer before anything must be sure of the safety of its employees especially the ones working in mines or any…Continue

Tags: products, safety

Started by Enna Henry. Last reply by Tara safe Aug 16.

Lean Six Sigma Black Belt Training in New York City

Welcome to MSys Training! We thank you for visiting MSys LSSBB training page. Attend our 4 days Lean Six Sigma Black Belt (LSSBB) training program with 100% pass rate, high quality course material,…Continue

Tags: sigma, six

Started by rodriguezcecelia Aug 11.

ITIL Certification Training - MSysTraining

The ITIL® Foundation is an entry level qualification in Information Technology industry. It gives participants information about the key elements, terminologies and concepts used in the ITIL Service…Continue

Tags: itil

Started by rodriguezcecelia Aug 8.

Badge

Loading…

© 2017   Created by Safety Community.   Powered by

Badges  |  Report an Issue  |  Terms of Service